Roseola future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Category |
||
Line 9: | Line 9: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Neurology]] | |||
[[Category:Pediatrics]] | |||
[[Category:Dermatology]] |
Revision as of 20:39, 21 September 2017
Roseola Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Roseola future or investigational therapies On the Web |
American Roentgen Ray Society Images of Roseola future or investigational therapies |
Risk calculators and risk factors for Roseola future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]